Dasatinib reduces 5-Fu-triggered apoptosis in colon carcinoma by directly modulating Src-dependent caspase-9 phosphorylation

Preclinical data have revealed the inhibitory effect of dasatinib on colon cancer. However, a combination of dasatinib and conventional chemotherapy has failed to show any meaningful outcome in a series of clinical trials. We, therefore, wondered whether Src kinase inhibitors were suitable for treat...

Descripción completa

Detalles Bibliográficos
Autores principales: Fu, Yang, Yang, Ge, Xue, Peipei, Guo, Luwei, Yin, Yuhan, Ye, Zhiqiang, Peng, Sanfei, Qin, Yanru, Duan, Qiuhong, Zhu, Feng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5966379/
https://www.ncbi.nlm.nih.gov/pubmed/29844931
http://dx.doi.org/10.1038/s41420-018-0062-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5966379/
https://www.ncbi.nlm.nih.gov/pubmed/29844931
http://dx.doi.org/10.1038/s41420-018-0062-5

Ejemplares similares